Dr. Kevin J Mcclelland MD

Recommended Articles

• High Prevalence of Celiac Disease in North India

  Celiac disease is a genetic autoimmune disease that causes the patients to suffer attacks to the small intestine whenever they ingest products with gluten. It’s estimated that one in one hundred people worldwide suffer from celiac disease and that approximately one in ten people in north India...

• Gluten-Free Food Bank Helps Families in Need in Massachusetts

  Celiac disease is a chronic condition caused in the digestive tract, it has an immunological origin characterized by a permanent intolerance to a protein called gluten which is present in cereals (wheat, oats, barley or rye). When the patient ingests foods containing gluten, the lining of the small...

• What Are the Risk Factors for Liver Cancer?

  A liver cancer risk factor is something that increases your chances of getting liver cancer. Different types of cancer have different risk factors. Some risk factors can be controlled such as smoking. On the other hand, age and family history cannot be changed, which means that some risk factors...

• Does My Diet Raise My Risk for Appendicitis?

  Many people pay little to no attention to the appendix. In fact, the appendix is probably the least studied organ in the body. The case can be confirmed by the fact that even in today’s highly advanced doctors and scientists, they still do not know the exact role of the appendix.The Role and...

• How to Diagnose and Treat Gallstones

  Who are at risk of developing gallstones?- Obesity is one of the biggest risk factors in developing gallstones. It increases a person's overall cholesterol levels, making it difficult to maintain a completely empty bladder. - Women who are pregnant, on birth control pills, or taking hormonal...

• New Treatment for Celiac Disease Using Nanoparticles Is Underway

  Recently, investigators have found a potential way to develop a treatment for celiac disease, which, according to Cour Pharmaceuticals focuses on the autoimmune disease, along with other inflammatory diseases. The treatment has been approved for clinical trials in August, 2017, and these trials have...